Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAquis Exchange Regulatory News (AQX)

Share Price Information for Aquis Exchange (AQX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 417.00
Bid: 414.00
Ask: 420.00
Change: 8.00 (1.96%)
Spread: 6.00 (1.449%)
Open: 409.00
High: 417.00
Low: 409.00
Prev. Close: 409.00
AQX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

9 Sep 2020 07:00

RNS Number : 3978Y
Aquis Exchange PLC
09 September 2020
 

9 September 2020

Aquis Exchange PLC

("Aquis", the "Company" or the "Group")

 

Interim results for the six months ended 30 June 2020

Continued strong growth and first period of profit

 

Aquis Exchange PLC (AQX.L), the exchange services group, is pleased to announce its unaudited results for the six months ended 30 June 2020.

 

Highlights:

· Revenue increased 42% to £4.9 million (1H19: £3.4 million)

· EBITDA of £0.54 million (1H19: £0.18 million loss)

· Profitability reached for the first time with a profit after tax of £16,000 (1H19: £623,000 loss)

· Cash and cash equivalents at 30 June 2020 of £11.2 million (30 June 2019: £11.2 million)

· Market share of all pan-European trading rose to 4.51% (1H19: 3.56%), despite the increased volatility driving significant additional proprietary trading

· The share of available liquidity increased further to 21% (1H19: 19%)

· Following approval from the FCA, the acquisition of Aquis Stock Exchange (AQSE) was completed on 11 March 2020 (formerly NEX Exchange)

• Integration into the Group progressing well

• Cost savings derived from synergies ahead of management expectations so far

• Three new companies quoted on AQSE since acquisition, one of which was post-period end

 

Post-period highlights:

· Current trading in line with market expectations for the full year, although we recognise the volatility of licensing contracts and their timing in this climate and their potential effect on revenues

· Plans to enhance Aquis Stock Exchange announced:

• Segmenting the market

• Gaining greater institutional and asset manager support 

• Prohibiting short selling

• Enhancing trading mechanisms

 

 

Alasdair Haynes, Chief Executive Officer of Aquis, commented:

 

"We are pleased to announce our first period of profitability, reached through further strong revenue growth. This growth has been driven by our existing Members continuing to increase their trading volumes through our pan-European lit equities market.

 

The completion of the acquisition of Aquis Stock Exchange in March was a milestone for the Group and marked a significant step towards achieving our ambition to become the leading exchange services group in Europe. We have now entered the primary listings market, with exciting plans in motion to further build AQSE into the first choice for quality growth businesses.

 

Despite the impact of Covid-19 on the global economy and business confidence, Aquis has maintained a robust competitive position in the marketplace and has successfully operated almost entirely remotely since March, highlighting the flexibility and resilience of the business.

 

While we anticipate the prevailing economic uncertainty will continue to impact market participants in the short to medium term, we have proven we have the right model, team, technology and vision to deliver shareholder value and look to the future with confidence." 

 

 

The Company is hosting a webinar for retail investors at 11.30am on Friday 11 September 2020. If you would like to attend this presentation, please register using the following link: http://bit.ly/AQX_H1202_piworldwebinar

 

 

This announcement contains inside information for the purposes of EU Regulation 596/2014.

 

 

 

 

Enquiries:

 

Aquis Exchange PLC

Tel: +44 (0)20 3597 6321

Alasdair Haynes, CEO

 

Jonathan Clelland, CFO and COO Belinda Keheyan, Head of Marketing

 

Tel: +44 (0)20 3597 6329

Liberum Capital Limited (Nominated Adviser and Broker)

Tel: +44 (0)20 3100 2000

Clayton Bush

 

Chris Clarke

 

Edward Thomas

 

Kane Collings

 

 

Alma PR (Financial PR Adviser)

Tel: +44 (0)20 3405 0209

Susie Hudson

Rebecca Sanders-Hewett

aquis@almapr.co.uk

Caroline Forde

 

   

 

 

Notes to editors:

 

Aquis Exchange PLC is an exchange services group, which operates a pan-European cash equities trading business (Aquis Exchange) and develops and licenses exchange software to third parties (Aquis Technologies).

 

Aquis Exchange PLC (AQX.L) is quoted on the London Stock Exchange's Alternative Investment Market (AIM).

 

Aquis Exchange is authorised and regulated by the UK Financial Conduct Authority and France's Autorité des Marchés Financiers to operate Multilateral Trading Facility businesses in the UK and in EU27 respectively.

 

Aquis operates a lit order book and does not permit aggressive non-client proprietary trading, which has resulted in lower toxicity and signalling risk on Aquis than other trading venues in Europe. According to independent studies, trades on Aquis are less likely to lead to price movement than on other lit markets. Aquis applies a subscription pricing model which works by charging users according to the message traffic they generate, rather than a percentage of the value of each security that they execute. This model can significantly reduce the cost of trading.

 

Aquis Technologies is the software and technology division of Aquis Exchange PLC. It creates and licenses cutting-edge, cost-effective matching engine and trade surveillance technology for banks, brokers, investment firms and exchanges.

 

Aquis Stock Exchange (AQSE) is a UK-based stock market providing primary and secondary markets for equity and debt products. It is permissioned as a Recognised Investment Exchange, which allows it to operate a regulated listings venue.

 

For more information, please go to www.aquis.eu and www.aquis.technology

 

Chief Executive Officer's Report

 

The six months to 30 June 2020 have been another strong period of growth and we are very pleased to have recorded our first period of profit. Alongside this we have maintained our competitive position in the market and made good operational progress to help drive us forward towards our long-term goals. The fact that we have achieved all this amidst the challenging economic circumstances arising from the global Covid-19 pandemic demonstrates our strong operational resilience and the continued demand for our unique offering.

 

A highlight of the Group's growth journey so far was the announcement of the completion of the acquisition of Aquis Stock Exchange in March 2020 and we have been rapidly developing the market since. The acquisition has further strengthened our position by allowing us to access new opportunities in the primary listings market and we are excited to build it into a true home for quality growth businesses, aligning it with Aquis' overall strategy and vision. Our planned enhancements for the market, following a consultation process, have now been formulated and are laid out in further detail below. So far we have been very pleased with the progress made, with cost savings derived from synergies between our business activities ahead of management expectations and with the transfer of the business onto the core Aquis technology platform scheduled for mid-September.

 

Covid-19 Update

 

As previously communicated, the Group had well-established remote working policies and disaster recovery plans, which were put into practice in March as a result of Covid-19. The market has been successfully operating almost entirely remotely since. Thanks to our focus on technology and in line with being a relatively small and agile operation, we have continued to serve our clients effectively whilst also pushing ahead with key strategic initiatives. Whilst the uncertainty and market turmoil has inevitably impacted decision making processes in the industry, we are pleased to have made significant progress with our KPIs (see below) and delivered our first period of profitable trading.

 

During the early weeks of the pandemic we saw greatly increased market volumes, which had a positive short-term impact. Since then trading levels have been closer to historic averages.

 

It is difficult to predict the medium to long term impact on the financial industry and more particularly equity market trading volumes, however, our business model continues to show its strength and we are confident we have the right strategy in place to continue delivering significant growth over the long term.

 

Operational Review

 

Aquis continued to develop its three complementary business activities throughout the period: its pan-European lit equities market: a multi-asset class technology licensing service to an international client base, a market data offering and, as of March, a fourth activity with our primary listings market for small and mid-cap companies. All activities have contributed to the significant growth experienced in the period and this is set to continue as synergies are developed and business potential is harnessed.

 

We continue to invest in key personnel in all areas, who will be instrumental in the business development process. The strength, experience and commitment of our staff, who have also demonstrated a commendable ability to adapt to the strange and unforeseen circumstances in the current environment, continue to be a significant contributor to our success.

 

We were also delighted to announce, post period, that the University of Derby has secured funding for a new knowledge transfer partnership with Aquis, in which we will collaborate on a research and development project based around machine learning, artificial intelligence and market surveillance. We firmly believe that this is where the future of surveillance lies and our philosophy at Aquis is to be always at the cutting edge of innovation.

 

A summary of progress in each of our business activities is outlined below.

 

Aquis Exchange

Continued strong growth in the core business

 

The key performance indicators of the Aquis Exchange business grew during the period. Exchange revenue increased by £1.0m (37%) from £2.7 million to £3.7 million and the number of Members grew from 30 to 31. In addition, a number of Members increased their trading volumes resulting in increased monthly subscriptions. This occurred against the backdrop of increased turbulence and uncertainty in financial markets as a result of Covid-19, which saw an increase in volatility and overall trading levels amid growing unease regarding the global economic outlook. Aquis Exchange's market share of all pan-European trading was at 4.51% (1H19: 3.56%), despite the increased volatility which drove significant additional proprietary trading and subsequently impacted auction performance.

 

The Company currently has an offering in excess of 1,500 stocks and ETFs across 14 European markets, an increase year on year.

 

Available liquidity on the exchange further increased to 21% in 1H20 (19% in 1H19) and it is expected this will underpin future anticipated growth.

 

The Group's Market at Close product ("MaC") has continued to attract interest since its launch in August 2019. It reached 3.52% of total pan-European auction volumes in December last year and, on average, achieved 3.61% in the first half of 2020 despite the challenging circumstances. Since the period end, MaC volumes have strengthened further.

 

The recognition that Aquis Exchange's toxicity is materially lower than its competitors continues to grow amongst investment managers and the wider market. With several market drivers pushing market participants towards lower toxicity, the opportunity for Aquis Exchange to attract a wider membership from across Europe and to facilitate increased trading volumes remains significant.

 

Aquis Stock Exchange

Building the home for quality growth businesses

 

AQSE is a modern market for modern business, bringing positive disruption and competition to the listed SME sector. It champions entrepreneurship, investment and growth. Innovation drives its thinking, regulation underpins its products and service culture guides its behaviour. It uses superior technology to deliver better results for all participants.

 

As one of the only two existing options for growing SMEs looking to IPO in the UK, Aquis' vision is for AQSE to become the home for quality growth businesses, applying core Aquis values such as transparency and innovation.

 

AQSE has committed to enhancing the market through the following four key actions:

1. Segmenting the market

- providing appropriate support throughout the growth cycle

2. Gaining greater institutional and asset manager support 

3. Prohibiting short selling

- protecting issuers and investors

4. Enhancing trading mechanisms

- supporting greater liquidity

 

These enhancements have been developed following our recent market consultation process, which saw a broad range of stakeholders taking part including issuers, investors, corporate advisers, lawyers, accountants, brokers, market makers institutions and industry think tanks.

 

A video providing further detail is available to view on the Company's website here: https://bit.ly/2QPC578. A further consultation on rule book changes took place across July and August, with the new policies anticipated to go live in Autumn this year.

 

Since acquisition, AQSE has been undergoing migration onto the Aquis trading platform and surveillance systems, with harmonisation in systems and processes being the first step in aligning the business with Aquis' strategic objectives.

 

Three listings have been completed since acquisition, in the beverages, industrial engineering and health care equipment & services sectors. All were well supported and there is an encouraging pipeline of businesses in conversation with AQSE regarding IPO.

 

As previously communicated, the Group remains committed to significantly reducing the loss generated by AQSE in the near term and good progress has been made in achieving the anticipated cost synergies, ahead of Management's original expectations.

 

Aquis Technologies

Revenue increased despite challenging market conditions

 

Aquis licenses its leading exchange-related technology through its Aquis Technologies division. Aquis Technologies creates and licenses technology for high volume, low latency trading platforms, complex connectivity solutions and real-time trade monitoring and surveillance systems for banks, brokers, investment firms and exchanges.

 

Despite the challenging market for new sales created by the Covid-19 pandemic, Aquis Technologies' revenue grew to £0.79m (1H19: £0.70m), driven by new licencing and support contracts, alongside revenue from the delivery of a number of implementations across a variety of asset classes, mandated in previous periods. Clients and prospects' decision processes have been delayed due to the Covid-19 pandemic but in the medium term this should improve as conditions begin to normalise.

 

Aquis will be focused on furthering the growth of the Technologies division, developing its products and services to help its clients with the challenges they face and ensuring the high-performance systems continue to be enhanced.

 

Aquis Market Data

 

Revenue from market data vendors more than doubled from £0.15m to £0.37m for the 6-month period compared to the 2019 equivalent. The consolidation of AQSE has helped to boost data revenues and the number of data vendors on the Aquis Exchange.

 

Financial Review

 

Revenue increased 42% to £4.9m (1H19: £3.4m) and the EBITDA profit for the half year was £0.54m, which compares to an EBITDA loss of £0.18m in 1H19. This EBITDA profit and the profit after tax of £16,000 includes income recognised from an £183,000 impairment credit per IFRS 9. The EBITDA profit growth is mainly attributable to increased exchange revenue as Members' subscriptions have risen as a result of increased trading levels. The Group made some controlled increases in costs during 1H 2020 as it continues to invest in personnel and technological resources and the Group will continue to invest on a controlled basis going forward.

 

The Company's cash and cash equivalents as at 30 June 2020 were £11.2 million (30 June 2019: £11.2 million), demonstrating its continued focus on careful cash management.

 

Summary

 

Our strategic goal is to become one of the leading exchange services groups through delivering best-in-class exchange trading opportunities, underpinned by our commitment to first class client service. To this end, our investment in R&D will help improve the trading experience for clients, as well as improving our market position and providing further growth and value creation for shareholders. Having made a significant amount of investment in the first half, we will see the full impact flow through into the full year.

 

Alongside this we are working to enhance our software licensing activities and build presence internationally.

 

AQSE has been successfully integrated into the business and we are in the process of building it into a quality home for growth companies. This will include a business development process focussing in particular on listing opportunities and synergies with Aquis Exchange activities, supported by an investment in key personnel.

 

Looking forward, our focus continues to be on executing on our core growth strategy; increasing trading volumes and improving fundraising prospects for small and mid-cap companies. Although uncertainty understandably continues to weigh on decision making we have already proven ourselves to be able to adapt to adversity and proactively seek out new opportunities.

 

Notwithstanding the macroeconomic uncertainty, current trading is in line with market expectations for the full year. I am confident that with our philosophy of fairness, transparency and simplicity, we have a winning formula. We have a strong team, experienced management and a cutting-edge technology platform. We are well placed to continue on our successful journey.

 

 

Alasdair Haynes

Chief Executive Officer

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Condensed consolidated statement of comprehensive income for the six-month period ended 30 June 2020

 

 

 

6 months ended 30/06/2020

 

Year ended 31/12/2019

 

6 months ended 30/06/2019

 

Note

 

£'000

 

£'000

 

£'000

Income Statement

 

 

 

 

 

 

 

Revenue

3

 

4,851

 

6,892

 

3,419

Impairment credit

4

 

183

 

243

 

120

Administrative expenses

 

 

(4,497)

 

(7,334)

 

(3,722)

Operating profit/(loss)

 

 

537

 

(199)

 

(183)

Investment income

5

 

14

 

42

 

21

Depreciation and amortisation

7,8

 

(522)

 

(928)

 

(439)

Net finance costs

16

 

(17)

 

(41)

 

(20)

Net profit (loss) before taxation

 

 

12

 

(1,126)

 

(621)

Income tax credit/(expense)

 

 

-

 

265

 

-

Profit/(loss) for the period

 

 

12

 

(861)

 

(621)

 

 

 

 

 

 

 

 

Other comprehensive income

 

 

 

 

 

 

 

Items that may be reclassified subsequently to profit or loss:

 

 

 

 

 

 

 

Foreign exchange differences on translation of foreign operations, net of tax

15

 

4

 

1

 

(2)

Other comprehensive profit / (loss) for the period

 

4

 

1

 

(2)

 

 

 

 

 

 

 

 

Total comprehensive profit / (loss) for the period

 

16

 

(860)

 

(623)

 

 

 

 

 

 

 

 

Earnings per share (pence)

6

 

 

 

 

 

 

Basic

 

 

 

 

 

 

 

Ordinary shares

 

 

0

 

(3)

 

(2)

Diluted

 

 

 

 

 

 

 

Ordinary shares

 

 

0

 

(3)

 

(2)

 

The consolidated statement of comprehensive income has been prepared on the basis that all operations are continuing operations.

 

 

 

 

 

 

 

 

 

 

 

 

Condensed consolidated statement of financial position as at 30 June 2020

 

 

 

6 months ended 30/06/2020

 

Year ended 31/12/2019

 

6 months ended 31/12/2019

 

Note

 

£'000

 

£'000

 

£'000

Assets

 

 

 

 

 

 

 

Non-current assets

 

 

 

 

 

 

 

Intangible assets

7

 

815

 

753

 

695

Property, plant and equipment

8

 

1,612

 

2,014

 

1,900

Trade and other receivables

9

 

947

 

967

 

862

 

 

 

3,374

 

3,734

 

3,457

Current assets

 

 

 

 

 

 

 

Trade and other receivables

9

 

2,742

 

1,654

 

2,152

Cash and cash equivalents

 

 

11,182

 

11,011

 

11,212

 

 

 

13,924

 

12,665

 

13,364

 

 

 

 

 

 

 

 

Total assets

 

 

17,298

 

16,399

 

16,821

Liabilities

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

 

Trade and other payables

10

 

2,329

 

1,500

 

1,650

 

 

 

 

 

 

 

 

Non-current liabilities

 

 

 

 

 

 

 

Lease liabilities

16

 

1,092

 

1,190

 

1,283

Total liabilities

 

 

3,421

 

2,689

 

2,933

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net assets

 

 

13,877

 

13,710

 

13,888

 

 

 

 

 

 

 

 

Equity

 

 

 

 

 

 

 

Called up share capital

11

 

2,717

 

2,715

 

2,715

Share premium account

12

 

10,892

 

10,840

 

10,840

Other reserves

13

 

311

 

213

 

153

Retained earnings/accumulated losses

14

 

(47)

 

(59)

 

182

Foreign currency translation reserve

15

 

4

 

1

 

(2)

Total equity

 

 

13,877

 

13,710

 

13,888

 

The notes to the financial statements on pages 7 to 16 form an integral part of these financial statements. The interim financial statements were approved by the board of directors and authorised for issue on 8th September 2020 and are signed on its behalf by:

 

J Clelland

Director

 

A Haynes

Director

 

Company Registration No. 07909192

 

 

Condensed consolidated statement of changes in equity for the period ended 30 June 2020

 

 

Note

Share Capital

 

Share Premium

 

Other Reserves

 

Retained Earnings

 

Foreign Currency Translation Reserve

 

Total

 

 

£'000

 

£'000

 

£'000

 

£'000

 

£'000

 

£'000

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at 1 January 2019

 

2,715

 

10,840

 

92

 

803

 

-

 

14,450

 

 

 

 

 

 

-

 

 

 

 

 

 

Loss for the 6-month period ended 30/06/2019

-

 

-

 

-

 

(621)

 

-

 

(621)

Foreign exchange differences on translation of foreign operations

 

-

 

-

 

-

 

-

 

(2)

 

(2)

Movement in share option reserve

-

 

-

 

61

 

-

 

-

 

61

Balance at 30 June 2019

 

2,715

 

10,840

 

153

 

182

 

(2)

 

13,888

Loss for the 6-month period ended

31/12/2019

 

 

 

(241)

 

 

 

(241)

Foreign exchange differences on translation of foreign operations

 

 

 

 

 

 

 

 

 

3

 

 

 

3

Movement in share option reserve

 

 

 

60

 

 

 

 

 

60

Balance at 31 December 2019

2,715

 

10,840

 

213

 

(59)

 

1

 

13,710

Profit for the 6-month period ended

30/06/2020

 

 

 

12

 

 

 

12

Foreign exchange differences on translation of foreign operations

15

 

 

 

 

 

 

 

 

3

 

3

Movement in share option reserve

13

 

 

 

 

98

 

 

 

 

 

98

Issue of new shares

11,12

2

 

52

 

 

 

 

 

 

 

54

Balance at 30 June 2020

 

2,717

 

10,892

 

311

 

(47)

 

4

 

13,877

                 
 

 

Condensed consolidated statement of cash flows for the period ended 30 June 2020

 

 

 

Note

6 months ended 30/06/2020£'000

 

Year ended 31/12/2019£'000

 

6 months ended 30/06/2019£'000

 

 

 

 

 

 

 

 

 

Cash flows from operating activities

 

 

 

 

 

 

 

Cash generated/absorbed by operations

17

568

 

386

 

62

 

Tax refunded

 

 

-

 

265

 

-

 

Finance expense on lease liabilities

16

(17)

 

(48)

 

(24)

 

Net cash inflow from operating activities

552

 

603

 

38

 

 

 

 

 

 

 

 

 

Investing Activities

 

 

 

 

 

 

 

 

Recognition of intangible assets

7

(311)

 

(562)

 

(281)

 

Purchase of property, plant and equipment

8

(44)

 

(509)

 

(181)

 

Interest received

 

5

14

 

42

 

21

 

Net cash used in / generated by investing activities

(341)

 

(1,029)

 

(441)

 

 

 

 

 

 

 

 

 

Financing Activities

 

 

 

 

 

 

 

 

Proceeds from share issue

11,12

54

 

 

 

 

 

Principal portion of lease liability

16

(98)

 

(183)

 

-

 

Net cash (used in)/ generated by financing activities

(44)

 

(183)

 

 

 

 

 

 

 

 

 

 

 

Net increase/(decrease) in cash and cash equivalents

167

 

(609)

 

(403)

Cash and cash equivalents at the beginning of the period

11,011

 

11,619

 

11,610

Effect of exchange rate changes on cash and cash equivalents

4

 

1

 

2

Cash and cash equivalents at the end of the period

11,182

 

11,011

 

11,209

 

 

 

Notes to the financial statements

 

1. Basis of preparation of half-year report

This condensed consolidated interim financial report for the half-year reporting period beginning 1 January 2020 and ending 30 June 2020 ("interim period") has been prepared in accordance with Accounting Standard IAS 34 Interim Financial Reporting.

The interim report does not include all the notes of the type normally included in an annual financial report. Accordingly, this report is to be read in conjunction with the annual report for the year ended 31 December 2019 and any public announcements made by Aquis Exchange PLC ("Aquis" or the "Company") during the interim reporting period.

The accounting policies adopted are consistent with those of the previous financial year and corresponding interim reporting period.

 

2. Significant changes in the current reporting period

The financial position and performance of the group was particularly affected by the following events and transactions during the six months to 30 June 2020:

· The consolidation of newly acquired subsidiary, Aquis Stock Exchange (AQSE); and

· An increase in revenue as a result of an increase in exchange members and trading volumes.

During the interim period, the acquisition of NEX Exchange Limited was approved by the FCA and was completed on 11th March 2020. The company was renamed Aquis Stock Exchange (AQSE) and has been included in the Consolidated Financial Statements for the Aquis Exchange PLC Group ("Group") for the period since acquisition.

The coronavirus pandemic has had an unprecedented impact on markets around the world in the first half of 2020. The principal impact of the pandemic on the Group has been through increased market volatility and a slower than expected pace of onboarding new clients.

However, despite challenging market conditions during the six months ended 30 June 2020, Aquis generated a profit of £12k, largely the result of growing Exchange revenues.

 

3. Revenue

An analysis of the Group's revenue is as follows:

 

6 months ended 30/06/2020

 

Year ended 31/12/2019

 

Restated 6 months ended 30/06/2019

 

£'000

 

£'000

 

£'000

Exchange Fees

3,682

 

5,285

 

2,675

Licence Fees

607

 

1269

 

590

Issuer Fees

189

 

-

 

-

Data Vendor Fees

373

 

338

 

154

 

4,851

 

6,892

 

3,419

4. Expected credit loss

The expected credit loss on licensing contract assets has been calculated in accordance with IFRS 9:

 

£'000

 

 

As at 31/12/2018

696

Expected credit loss reversal for the period

(120)

As at 30/06/2019

576

Expected credit loss reversal for the period

(123)

As at 31/12/2019

453

Expected credit loss reversal for the period

(183)

As at 30/06/2020

270

 

5. Investment income

 

6 months ended 30/06/2020

 

Year ended 31/12/2019

 

6 months ended 30/06/2019

 

£'000

 

£'000

 

£'000

Interest income

 

 

 

 

 

Bank deposits

14

 

42

 

21

 

6. Earnings per share

 

6 months ended 30/06/2020

 

Year ended 31/12/2019

 

6 months ended 30/06/2019

 

 

 

 

 

 

Number of Shares ('000)

 

 

 

 

 

Weighted average number of ordinary shares for basic earnings per share

27,158

 

27,150

 

27,150

Weighted average number of ordinary shares for diluted earnings per share

28,043

 

27,714

 

27,710

Earnings (£'000)

 

 

 

 

 

Profit for the period from continued operations

12

 

(862)

 

(623)

Basic and diluted earnings per share (pence)

 

 

 

 

 

Basic earnings per ordinary share

0

 

(3)

 

(2)

Diluted earnings per ordinary share

0

 

(3)

 

(2)

 

 

 

 

7. Intangible assets

 

£'000

 

 

Cost

 

As at 31/12/2018

1,493

Additions- internally generated

281

As at 30/06/2019

1,774

Additions- internally generated

281

As at 31/12/2019

2,055

Additions- internally generated

311

As at 30/06/2020

2,366

 

 

Accumulated amortisation and impairment

 

 

 

As at 31/12/2018

855

Charge for the period

224

As at 30/06/2019

1,079

Charge for the period

223

As at 31/12/2019

1,302

Charge for the period

249

As at 30/06/2020

1,551

 

 

Carrying amount

 

As at 31/12/2018

638

As at 30/06/2019

695

As at 31/12/2019

753

As at 30/06/2020

815

 

8. Property, plant and equipment

 

Fixtures, fittings and equipment

 

Computer Equipment

 

Non-current portion of IFRS 16 leased assets

 

Total

 

£'000

 

£'000

 

£'000

 

£'000

Cost

 

 

 

 

 

 

 

As at 31/12/2018

246

 

1,592

 

-

 

1,838

Additions & disposals

-

 

302

 

-

 

302

As at 30/06/2019

246

 

1,894

 

1,271

 

3,411

Additions & disposals

3

 

203

 

-

 

207

As at 31/12/2019

249

 

2,097

 

1,271

 

3,617

Additions & disposals

-

 

44

 

-

 

44

As at 30/06/2020

249

 

2,141

 

1,271

 

3,661

 

 

 

 

 

 

 

 

Accumulated depreciation and impairment

 

 

 

 

 

 

 

As at 31/12/2018

78

 

1,219

 

-

 

1,297

Charge for the period

24

 

103

 

87

 

214

As at 30/06/2019

102

 

1,322

 

87

 

1,511

Charge for the period

25

 

154

 

86

 

267

As at 31/12/2019

127

 

1,476

 

173

 

1,778

Charge for the period

25

 

161

 

87

 

273

As at 30/06/2020

152

 

1,637

 

260

 

2,049

 

 

 

 

 

 

 

 

Carrying amount

 

 

 

 

 

 

 

As at 31/12/2018

169

 

373

 

-

 

542

As at 30/06/2019

144

 

572

 

1,184

 

1,900

As at 31/12/2019

122

 

621

 

1,098

 

1,841

As at 30/06/2020

97

 

504

 

1,011

 

1,612

 

9. Trade and other receivables

 

Current

 

As at 30/06/2020

 

As at 31/12/2019

 

As at 30/06/2019

 

£'000

 

£'000

 

£'000

Trade receivables net of impairment

2,204

 

1,481

 

1,712

Prepayments

340

 

166

 

254

Other receivables

198

 

7

 

186

 

2,742

 

1,654

 

2,152

 

 

 

 

 

 

 

Non-Current

 

As at 30/06/2020

 

As at 31/12/2019

 

As at 30/06/2019

 

£'000

 

£'000

 

£'000

Trade receivables net of impairment

729

 

752

 

650

Other receivables

218

 

215

 

212

 

947

 

967

 

862

 

Trade receivables are stated net of any credit impairment provision as set out previously in Note 3 in accordance with IFRS 9, as illustrated below:

 

 

 

 

As at 30/06/2020

 

As at 31/12/2019

 

As at 30/06/2019

(restated)

 

£'000

 

£'000

 

£'000

Gross trade receivables

3,283

 

2,686

 

2,938

Expected credit loss

(350)

 

(453)

 

(576)

Trade receivables net of impairment

2,933

 

2,233

 

2,362

 

Impairment includes the expected credit loss on licencing contract assets stated in Note 4.

 

10. Trade and other payables

 

As at 30/06/2020

 

As at 31/12/2019

 

As at 30/06/2019

 

 

 

 

Trade payables

90

 

130

 

271

 

 

Accruals

968

 

1,053

 

954

 

 

Social security and other taxation

370

 

174

 

107

 

 

Deferred revenue

709

 

-

 

-

 

 

Other payables

192

 

142

 

318

 

 

 

2,329

 

1,499

 

1,650

 

 

 

 

 

 

11. Called up share capital

 

 

As at 30/06/2020

 

As at 31/12/2019

 

As at 30/06/2019

 

£'000

 

£'000

 

£'000

Ordinary share capital

 

 

 

 

 

Issued and fully paid

 

 

 

 

 

27,149,559 Ordinary shares of 10p each

2,715

 

2,715

 

2,715

Issue of new shares following exercise of 20,137 EMI share options

2

 

 

 

 

At 30/06/2020

2,717

 

2,715

 

2,715

 

 

 

 

12. Share premium account

 

As at 30/06/2020

 

As at 31/12/2019

 

As at 30/06/2019

 

£'000

 

£'000

 

£'000

Share premium

 

 

 

 

 

At beginning of year

10,840

 

10,840

 

10,840

Issue of new shares following exercise of 20,137 EMI share options

52

 

-

 

-

 

 

 

 

 

 

At 30/06/2020

10,892

 

10,840

 

10,840

 

13. Other Reserves

 

As at 30/06/2020

 

As at 31/12/2019

 

As at 30/06/2019

 

£'000

 

£'000

 

£'000

Movement in reserves

98

 

60

 

61

Reserves relating to share-based payments

311

 

213

 

153

 

The reserves relating to share-based payments reflects the estimated value of the approved Employee Share Option Scheme and Restricted Share Awards Scheme estimated using a US binomial option valuation model.

 

14. Retained earnings

 

£'000

 

 

As at 31/12/2018

923

Adjustment arising due to IFRS 16

(120)

Adjusted opening balance as at 31/12/2018

803

Loss for the 6-month period ended 30/06/2019

(621)

As at 31/06/2019

182

Loss for the 6-month period ended 30/12/2019

(241)

As at 31/12/2019

(59)

Profit for the 6-month period ended 30/06/2020

12

As at 30/06/2020

(47)

 

15. Foreign currency translation reserve

Aquis Exchange PLC is regulated in the UK by the FCA but with increasing uncertainty over the outcome of Brexit the Company decided to establish a European subsidiary and in March 2019 successfully applied for regulatory approval to operate a Multilateral Trading Facility (MTF) in France through this subsidiary. The translation of the European subsidiary into the functional currency of the Group results in foreign exchange differences that have been recognised in Other Comprehensive Income ('OCI') for the Group which have been accumulated in a separate component of equity as illustrated below.

 

6 months ended 30/06/2020

 

Year ended 31/12/2019

 

6 months ended 30/06/2019

 

£'000

 

£'000

 

£'000

At the beginning of the year/period

-

 

-

 

-

Foreign exchange differences on translation of foreign operations recognised in OCI

4

 

1

 

(2)

At the end of the year/period

4

 

1

 

(2)

 

16. IFRS 16 Leases

 

 

 

 

 

 

 

 

The impact on the Group's assets and liabilities, and the related effects on profit and loss, of the Group's leasing activities

(the Group as a lessee) are detailed below.

 

 

 

 

 

 

 

 

Right of Use Asset

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Property

 

£

Carrying amount at 1 January 2019

1,444

Depreciation for the period

(87)

Carrying amount at 30 June 2019

1,358

Depreciation for the period

(87)

Carrying amount at 31 December 2019

1,271

Depreciation for the period

(87)

Carrying amount at 30 June 2020

1,184

Of which are:

 

Current

173

Non-current

1,011

 

1,184

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Rent deposit asset

 

 

 

 

 

 

 

 

 

Rent deposit asset

 

£

Carrying amount at 1 January 2019

215

Finance income on rent deposit asset for the period

3

Carrying amount at 30 June 2019

218

Finance income on rent deposit asset for the period

4

Carrying amount at 31 December 2019

222

Finance income on rent deposit asset for the period

3

Carrying amount at 30 June 2020

225

Of which are:

 

Current

7

Non-current

218

 

225

 

 

 

 

 

 

 

 

Lease liability

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Lease liability

 

£

Carrying amount at 1 January 2019

1,561

Finance expense on lease liability for the period

24

Lease payments made during the period

(115)

Carrying amount at 30 June 2019

1,470

Finance expense on lease liability for the period

24

Lease payments made during the period

(116)

Carrying amount at 31 December 2019

1,378

Finance expense on lease liability for the period

21

Lease payments made during the period

(115)

Carrying amount at 30 June 2020

1,284

Of which are:

 

Current

192

Non-current

1,092

 

 1,284

 

 

 

 

 

 

 

 

 

 

Net finance expense on leases

 

 

 

 

 

 

 

6 months ended 30/06/2020

Year ended 31/12/2019

6 months ended 30/06/2019

 

£

£

£

Finance expense on lease liability

21

48

24

Finance income on rent deposit asset

(4)

(7)

(3)

Net finance expense relating to leases

17

41

21

 

 

The finance income and finance expense arising from the Group's leasing activities as a lessee have been shown net where applicable

 as is permitted by IAS 32 where criteria for offsetting have been met.

 

 

 

 

 

 

 

 

Amounts recognised in profit and loss

 

 

 

 

 

 

 

6 months ended 30/06/2020

Year ended 31/12/2019

6 months ended 30/06/2019

 

£

£

£

Depreciation expense on right-of-use assets

(87)

(173)

(87)

Finance expense on lease liability

(21)

(48)

(24)

Finance income on rent deposit asset

3

7

3

Net impact of leases on profit or loss

(105)

(214)

(108)

 

 

 

 

 

 

 

 

 

 

The total cash outflow for leases amounted to £115k in the 6 months to 30th June 2020.

 

17. Cash generated from operations

 

6 months ended 30/06/2020

 

Year ended 31/12/2019

 

Restated 6 months ended 30/06/2019

 

£'000

 

£'000

 

£'000

 

 

 

 

 

 

Profit / (loss) after tax

12

 

(862)

 

(621)

 

 

 

 

 

 

Adjustments for:

 

 

 

 

 

Taxation

-

 

(265)

 

-

Investment revenue

(14)

 

(42)

 

(21)

Amortisation and impairment of intangible assets

249

 

447

 

223

Depreciation and impairment of property, plant and equipment

273

 

482

 

215

Equity settled share-based payment expense

98

 

120

 

61

Other losses

(29)

 

(24)

 

 

Losses on transition of accounting standards

-

 

(120)

 

(224)

 

 

 

 

 

 

Movement in working capital:

 

 

 

 

 

 

 

 

 

 

 

Increase in trade and other receivables

(850)

 

43

 

(329)

Increase in trade and other payables

829

 

607

 

758

 

 

 

 

 

 

Cash generated by operations

568

 

386

 

62

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR SSDFAAESSELU
Date   Source Headline
22nd Mar 20247:00 amRNSPublication of Annual Report and Notice of AGM
21st Mar 20247:00 amRNSResults for the year ended 31 December 2023
13th Mar 20247:00 amRNSContract with the Central Bank of Colombia
12th Mar 20247:00 amRNSAquis to Establish New Real Assets Market Segment
26th Feb 20247:00 amRNSAquis launches conditional order functionality
23rd Feb 20247:00 amRNSNotice of Results and Investor Presentation
25th Jan 20247:00 amRNSTrading Update and Notice of Results
23rd Jan 20243:15 pmRNSExercise of Share Options and Total Voting Rights
21st Dec 20231:15 pmRNSDirector/PDMR Notification
29th Nov 20237:00 amRNSAQSE becomes first cloud-based RIE
24th Nov 202312:00 pmRNSDirector/PDMR Notification
2nd Nov 20237:00 amRNSHolding(s) in Company
31st Oct 202311:55 amRNSBoard Change
18th Oct 20237:00 amRNSDirector/PDMR Shareholding
17th Oct 202312:39 pmRNSDirector/PDMR Shareholding
21st Sep 20237:00 amRNSInterim Results
12th Sep 20237:00 amRNSAquis Markets - Change to Proprietary Trading Rule
7th Sep 20237:00 amRNSNotice of Results and Investor Presentation
6th Sep 20237:00 amRNSAppointment of Nominated Adviser and Joint Broker
7th Aug 20232:15 pmRNSAcquisition of Minority Interest
28th Jun 20237:00 amRNSDirector/PDMR Shareholding
6th Jun 20237:00 amRNSDirector/PDMR Shareholding
6th Jun 20237:00 amRNSAquis launches Dark to Lit Sweep
27th Apr 20237:00 amRNSDirector/PDMR Notification and Issue of Options
25th Apr 20232:18 pmRNSResult of AGM
14th Apr 20237:00 amRNSPublication of Annual Report & Notice of AGM
6th Apr 20231:05 pmRNSHolding(s) in Company
4th Apr 20237:00 amRNSDirector/PDMR Shareholding
3rd Apr 202310:55 amRNSDirector/PDMR Shareholding
3rd Apr 20237:01 amRNSDirector/PDMR Shareholdings
3rd Apr 20237:00 amRNSAquis Launches The World’s First 24x7 Exchange
30th Mar 20237:00 amRNSFinal Results
22nd Feb 20237:00 amRNSNotice of Results and Investor Presentation
2nd Feb 20237:00 amRNSExercise of Share Options & Total Voting Rights
2nd Feb 20237:00 amRNSExercise of Share Options & Total Voting Rights
26th Jan 20237:00 amRNSTrading Update and Notice of Results
5th Jan 20237:00 amRNSDirectorate Change
12th Dec 20227:00 amRNSIG Expands UK Trading Offering With AQSE Stocks
24th Nov 20229:13 amRNSDirector/PDMR Notification
23rd Nov 20224:09 pmRNSDirector/PDMR Notification
2nd Nov 20227:00 amRNSNotice of Capital Markets Day
27th Sep 20227:00 amRNSNotice of Capital Markets Day
22nd Sep 20227:00 amRNSInterim Results
5th Sep 202212:00 pmRNSLaunch of new EU dark pool, Aquis Matching Pool
23rd Aug 20227:00 amRNSNotice of Results
6th Jul 202212:00 pmRNSAPEX stocks now trading on Hargreaves Lansdown
30th Jun 202212:49 pmRNSDirector/PDMR Notification and Issue of Options
23rd Jun 20227:00 amRNSDirector/PDMR Shareholding
22nd Jun 202212:30 pmRNSExercise of Share Options and Total Voting Rights
26th May 20227:00 amRNSChange of registered address

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.